FDA Inspection 854065 - GlaxoSmithKline dba Human Genome Sciences Inc - November 05, 2013
FDA Inspection 854065 for GlaxoSmithKline dba Human Genome Sciences Inc on November 05, 2013. Classification: No Action Indicated (NAI).
One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.
FDA Inspection 854065 for GlaxoSmithKline dba Human Genome Sciences Inc on November 05, 2013. Classification: No Action Indicated (NAI).
Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
Inspection Date
November 5, 2013
Product Type
Drugs
ID: fcad030a-10f3-4e6a-9baa-048402dcf430
View on DashboardTransform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox